FDA/CDRH – MDIC Co-Sponsored Public Meeting
Regulatory Science Innovations Catalyzing Medical Device Development
FDA/CDRH – MDIC Co-Sponsored Public Meeting
September 25, 2026 | FDA White Oak Campus, Silver Spring, MD and Virtual
8:30 AM – 4:30 PM ET
Meeting Overview and Objectives
The U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) and the Medical Device Innovation Consortium (MDIC) are co-sponsoring a one-day stakeholder engagement meeting focused on advancing regulatory science for breakthrough and disruptive medical device technologies. In conjunction with this meeting, the FDA is opening a docket to receive comments from the public.
The purpose of the meeting is to advance regulatory science in support of breakthrough devices and disruptive medical device technologies by fostering meaningful, multi-stakeholder dialogue to help inform long-term research priorities and strategic planning for FDA’s Center for Devices and Radiological Health (CDRH). Through this collaborative effort, CDRH and MDIC seek to identify the regulatory science challenges anticipated to impact medical device development over the next decade.
Visit the FDA Meeting Page for more information.
Meeting Objectives
Gather Stakeholder Perspectives
Gather stakeholder perspectives on emerging device technologies, evolving clinical scenarios, and their anticipated regulatory science needs.
Identify Critical Regulatory Science Gaps
Identify critical regulatory science gaps that could potentially impede the development of safe and effective novel devices and disruptive medical device technologies.
Join us In-Person or Online this September!
